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ABSTRACT
Designing of biologically active scaffolds with optimal characteristics is one of the key factors for
successful tissue engineering. Recently, hydrogels have received a considerable interest as leading
candidates for engineered tissue scaffolds due to their unique compositional and structural similarities
to the natural extracellular matrix, in addition to their desirable framework for cellular proliferation and
survival. More recently, the ability to control the shape, porosity, surface morphology, and size of
hydrogel scaffolds has created new opportunities to overcome various challenges in tissue engineering
such as vascularization, tissue architecture and simultaneous seeding of multiple cells. This review
provides an overview of the different types of hydrogels, the approaches that can be used to
fabricate hydrogel matrices with specific features and the recent applications of hydrogels in tissue
engineering. Special attention was given to the various design considerations for an efficient
hydrogel scaffold in tissue engineering. Also, the challenges associated with the use of hydrogel
scaffolds were described.
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1. INTRODUCTION
Tissue engineering is a rapidly expanding interdisciplinary field involving biomaterials science, cell
biology, cell-material interactions and surface characterization. Research in this field aims to restore,
preserve, or enhance tissue functions. It also aims to replace diseased or damaged organs, or tissues
that are defective or have been lost as a result of accidents or disease. Tissue engineering typically
involves four key components as illustrated in (Figure 1); (a) selected and isolated cells (progenitor
or stem cells from different origins), (b) biomaterial scaffolds which may be natural or synthetic,
to provide a platform for cell function, adhesion and transplantation, (c) signaling molecules such as
proteins and growth factors deriving the cellular functions of interest, and (d) bioreactors that support
a biologically active environment for cell expansion and differentiation such as cell culture.
Tissues or organs can be potentially developed via a number of approaches. The most common
approach (Figure 2) involves isolation of tissue-specific cells from the patient’s small tissue biopsy and
harvested in vitro. The isolated cells are then expanded and seeded into three-dimensional scaffold
that mimic the natural extracellular matrices (ECM) of the targeted tissues. The key functions of these
scaffolds are to (a) deliver the seeded cells to the desired site in the patient’s body, (b) encourage
cell-biomaterial interactions, (c) promote cell adhesion, (d) permit adequate transport of gases,
nutrients and growth factors to ensure cell survival, proliferation, and differentiation, (e) confer a
negligible inflammation extent or toxicity in vivo, and (f) control the structure and function of the
engineered tissue.1 The cell-loaded scaffolds are subsequently transplanted into the patient either
through direct injection with the aid of a needle or other minimally invasive delivery technique, or
through implantation of the fabricated tissue at the desired site in the patient’s body using surgery.2
Designing a scaffold with optimal characteristics is, as mentioned above, one of the main key
components for successful tissue engineering. Over the last decade, hydrogel scaffolds have received a
considerable attention due to their unique compositional and structural similarities to the natural
ECM in addition to their desirable framework for cellular proliferation and survival.
2. HYDROGELS, AN OVERVIEW
Hydrogels are three-dimensional networks composed of hydrophilic polymers crosslinked either
through covalent bonds or held together via physical intramolecular and intermolecular attractions.
Hydrogels can absorb huge amounts of water or biological fluids, up to several thousand %, and swell
readily without dissolving. The high hydrophilicity of hydrogels is particularly due to the presence
of hydrophilic moieties such as carboxyl, amide, amino, and hydroxyl groups distributed along the
backbone of polymeric chains. In the swollen state, hydrogels are soft and rubbery, resembling to
a great extent the living tissues. In addition, many hydrogels, such as chitosan and alginate-based
hydrogels show desirable biocompatibility.3
The appearance of hydrogels dates back more than fifty years, when Wichterle et al. (1955–1960)4
developed and investigated a poly(2-hydroxyethyl methacrylate)-based hydrogel for contact lens
applications. Since then, the research in the field of hydrogels has expanded dramatically particularly
in the last two decades. In addition, the uses of hydrogels have extended to cover a wide range of
applications that include, but are not limited to, drug delivery, wound healing, ophthalmic materials
and tissue engineering.5,6
Hydrogels usually reach their equilibrium swelling when a balance occurs between osmotic driving
forces, which encourage the entrance of water or biological fluids into the hydrophilic hydrogel matrix,
and the cohesive forces exerted by the polymer strands within the hydrogel. These cohesive forces
Figure 1. A schematic illustration of the four key components of tissue engineering.
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resist the hydrogel expansion and the extent of these forces depends particularly on the hydrogel
crosslinking density.7,8 In general, the more hydrophilic the polymer forming the hydrogel, the higher
the total water amount absorbed by the hydrogel. Equally, the higher the crosslinking extent of a
particular hydrogel, the lower the extent of the gel swelling. Hydrogels in their dried forms are usually
called “xerogels”, whereas, dry porous hydrogels resulting from the use of drying techniques such as
freeze-drying or solvent extraction are referred to as “aerogels”.7
2.1. Hydrogels as compared to gels
One of the common misconceptions in polymer science is the use of the concept “gel” instead of
“hydrogel” and vice verse. Gels are semi-solid materials made of hydrophilic polymers comprising
small amounts of solids, dispersed in relatively large amounts of liquid. However, gels may appear
more solid-like than liquid-like.9 Hydrogels are also made of hydrophilic polymer chains but they are
crosslinked and that enables them to swell while retaining their three-dimensional structure without
dissolving.10 Hence, the principle feature of hydrogels, that differentiates them from gels, is their
inherent crosslinking. However, gels can also get a low level of virtual crosslinking under the influence
of sheer forces, but this type of crosslinking is very weak and reversible.
Figure 2. Schematic illustration of the most common tissue engineering approaches. Tissue-specific cells are
isolated from a small biopsy from the patient, expanded in vitro, seeded into a well-designed scaffold and
transplanted into the patient either through injection, or via implantation at the desired site using surgery.
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2.2. Classifications of hydrogels
Numerous classifications have been applied to hydrogels as summarized in (Figure 3). Some of these
classifications are discussed below11:
2.2.1. According to hydrogel origin
Hydrogels can be classified into natural, synthetic and semi-synthetic according to their origin. Most of
the synthetic hydrogels are synthesized by traditional polymerization of vinyl or vinyl-activated
monomers. The equilibrium swelling values of these synthetic hydrogels vary widely according to the
hydrophilicity of the monomers and the crosslinking density. A bi-functional monomer is usually added
to carry out an in situ crosslinking reaction. Natural hydrogels are made of natural polymers including
polynucleotides, polypeptides, and polysaccharides. These natural polymers are obtained from various
natural origins. For instance, collagen is obtained from mammals whereas chitosan is obtained from
shellfish exoskeletons.
2.2.2. According to hydrogel durability
Hydrogels can be either durable (such as most polyacrylate-based hydrogels) or biodegradable
(such as polysaccharides-based hydrogels), depending on their stability characteristics in a
physiological environment. Recently, a significant body of research has focused on the fabrication and
utilization of new biodegradable hydrogels. Applications of these biodegradable hydrogels are now
covering many areas, including both biomedical and non-biomedical uses.12 The degradable polymers
inside the hydrogel matrices undergo chain scission to form oligomers of low molecular weight.
Then, the resulting oligomers are either eliminated by body or undergo further degradation.
2.2.3. According to hydrogel response to environmental stimuli
The past decade has witnessed vast advances in preparation and investigating a unique category of
hydrogels called “smart hydrogels”. In spite of the similarities with conventional types in preparation
methods and characterization techniques, smart hydrogels can, however exhibit unusual changes in
their swelling behavior, network structure and/or mechanical characteristics in response to various
environmental stimuli such as pH, temperature, light, ionic strength or electric field.13– 15 These changes
occur to smart hydrogels, in response to any of these environmental stimuli, usually disappear upon
removal of the stimulus and consequently the hydrogels restore their original state and so on in a
reversible manner. (Figure 4) illustrates, as example, the significant change in swelling extent of a smart
hydrogel in response to various environmental stimuli.
2.3. Methods of preparation of hydrogels
Hydrogels can be prepared by various methods depending on the designed structure and the desired
application. Some of these methods are discussed below and summarized in (Figure 5).
2.3.1. Free radical polymerization
Conventional free radical polymerization is the preferred technique for preparation of hydrogels based
on some monomers such as acrylates, amides and vinyl lactams.16,17 It can also be used for
Figure 3. Schematic diagram showing the most common classes of hydrogels.
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development of natural polymers-based hydrogels provided that these polymers have suitable
functional groups or have been functionalized with radically polymerizable groups. For instance, this
method has been used to develop various chitosan-based hydrogels.18,19 Preparation of hydrogels
using this technique involves the typical free radical polymerizations steps; initiation, propagation,
chain transfer and termination. In the initiation step a wide variety of visible, thermal, ultraviolet and
red-ox initiators can be used for radical generation. These radicals then react with monomers
converting them into active forms which react with more monomers and so on in the propagation
step. The resulting long chain radicals undergo termination either through chain transfer or through
radical combination forming polymeric matrices.
This method of hydrogel preparation can be performed either in solution or neat (bulk). Solution
polymerization is desirable during synthesis of large quantities of hydrogels and in this case, water is
the most commonly used solvent. Bulk polymerization, however is faster than solution polymerization
and does not need a solvent removal, which is time-consuming in many cases.
2.3.2. Irradiation crosslinking of hydrogel polymeric precursors
Ionizing-radiation techniques, especially if combined with a simultaneous sterilization process, are very
effective methods for synthesis of hydrogels. Ionizing radiations, such as electron beam and g–rays,
Figure 5. Schematic diagram showing the most common methods of preparation of hydrogels.
Figure 4. Stimuli-responsive swelling of a smart hydrogel.
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have high energy enough to ionize simple molecules either in air or water.11 During irradiation of a
polymer solution, many reactive sites are generated along the polymer strands. Then, the combination
of these radicals leads to formation of a large number of crosslinks. Formation of hydrogels using this
approach can be performed via irradiation of the polymers either in bulk or in solution. However,
irradiation of a polymer solution is the favored due to the less energy required for formation of
macroradicals. Besides, in solution the efficiency of radicals is high due to the reduced viscosity of
reaction mixture.
Applying irradiation to hydrogel development offers many advantages over other preparation
methods where, during the irradiation process, no catalysts or additives are needed to initiate the
reaction. Also, irradiation methods are simple and the crosslinking extent can be controlled easily by
varying the irradiation dose.20,21 Due to these advantages, this technique has been used for developing
a wide range of hydrogels for many biomedical applications, where even the slightest contamination is
undesirable. For example, it has been used efficiently to prepare acrylic acid hydrogels20 and
poly(ethylene glycol)/carboxymethyl chitosan-based pH-responsive hydrogels.22 However, this
technique is not recommended for preparation of hydrogels from some polymers that can degrade
under the ionizing irradiation.
2.3.3. Chemical crosslinking of hydrogel polymeric precursors
Chemical crosslinking of hydrophilic polymers is one of the main methods of hydrogel preparation.
In this technique, a bi-functional crosslinking agent is added to a dilute solution of a hydrophilic
polymer and the polymer should have a suitable functionality to react with the crosslinking agent. This
method is suitable for preparation of hydrogels from both natural and synthetic hydrophilic polymers.
For instance, albumin and gelatin–based hydrogels were developed using dialdehyde or formaldehyde
as crosslinking agents.23,24 Also hydrogels of high water content based on crosslinking of functionalized
polyethylene glycol and a lysine-containing polypeptide have been developed by this method.24
2.3.4. Physical crosslinking of hydrogel polymeric precursors
Crosslinking of polymers through physical interactions is one of the common approaches for hydrogel
formation. This physical crosslinking includes interactions such as polyelectrolyte complexation,
hydrogen bonding and hydrophobic association, and the hydrogels developed by this technique are
usually prepared under mild conditions.
a. Polyelectrolyte complexation (Ionic interactions): In this approach, hydrogels are prepared
through formation of polyelectrolyte complexes, where links are formed between pairs of charged sites
along the polymer backbones. The formed electrolytic links vary in their stabilities according to the pH
of the system. An example of hydrogels developed by this method are those resulting from the
polyelectrolyte complexation of the carboxylate groups of sodium alginate with the amino groups
distributed along chitosan chains.25
b. Hydrogen bonding: Hydrogen bonding between polymer chains can also participate in hydrogel
formation, for instance, in developing gelatin-based hydrogel.24 A hydrogen bond is formed through
the association of an electron deficient hydrogen atom and a functional group of high electronegativity.
Hydrogels developed by this technique are affected by many factors, such as polymer concentration,
molar ratio of each polymer, type of solvent, solution temperature, and the degree of association
between the polymer functionalities.
c. Hydrophobic association: A further methodology for obtaining Hydrogels is through
hydrophobic interactions.26 Polymers and copolymers, such as graft and block copolymers, usually
form structures separated by hydrophobic micro-domains. These hydrophobic domains act as
associated crosslinking points in the entire polymeric structure, and are surrounded by hydrophilic
water absorbing regions. This approach has been utilized to develop a hydrogel based on a graft-type
copolymer composed of hydrophilic poly(hydroxyethyl methacrylate) (PHEMA) as a backbone and a
small amount of hydrophobic poly(methylmethacrylate) (PMMA) as a long branch.26 In general, the
mechanical characteristics of these hydrophobically combined polymers are poor due to the poor
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interfacial adhesion. However, this approach for hydrogel preparation has some advantages such as
the low cost of the system.
2.4. Potential applications of hydrogels in tissue engineering
A significant body of research has focused recently on the utilization of hydrogels for various applications
in tissue engineering. For instance, hydrogels have been used as scaffolds that mimic the extracellular
matrices, to provide the structural integrity and bulk for cellular organization andmorphogenic guidance,
to encapsulate and deliver cells, to act as tissue barriers and bioadhesives, to serve as depots for drugs,
and to deliver bioactive moieties that encourage the natural reparative process.
2.4.1. Hydrogels as carriers for cell transplantation
Hydrogels can be ultimately beneficial in cell transplantation due to their unique ability to offer
immunoisolation while still allowing nutrients, oxygen, and metabolic products to diffuse easily into
their matrices. For instance, photo-polymerized poly(ethylene glycol) diacrylate, (PEG diacrylate)-based
hydrogels have been developed to transplant islets of Langerhans.27 In this study, the islet cells were
suspended in the photo-polymerizable polymer solution and the solution was then used to formulate
PEG-based microspheres that incorporated the islets. These PEG-based hydrogel microspheres
showed adequate immunoisolation but the diffusion ability of nutrients to the entrapped cells was
relatively limited. This shortcoming has been overcome through reducing the thickness of the
interfacially photo-polymerized hydrogel microspheres and consequently, the encapsulated islets
remained viable for prolonged periods and the hydrogel particles retained their immunoisolation
function.27 In another study,28 the in vitro potential of a metalloproteinase (MMP)-responsive
PEG-based hydrogel was investigated as bioactive co-encapsulation system for vascular cells and
a small bioactive peptide, thymosin beta4. The study demonstrated that incorporation of thymosin
beta4 in the matrix creates a three-dimensional environment favorable for human umbilical vein
endothelial cell (HUVEC) adhesion, survival, migration and organization. In addition, thymosin beta4
has improved the HUVEC attachment and induced vascular-like network formation within the
PEG-hydrogels. These developed MMP-responsive PEG-hydrogels may thus be tailored to serve as
controlled co-encapsulation system of vascular cells and bioactive agents for in situ regeneration of
ischemic tissues. In a recent study, Nichol et al.29 have developed gelatin methacrylate (GelMA) as an
inexpensive, cell-responsive hydrogel platform for creating cell-laden microtissues. The investigated
cells readily bound to, proliferated, elongated and migrated when encapsulated in the developed
microfabricated GelMA hydrogels.
2.4.2. Hydrogels as scaffolds
Hydrogels can be used in tissue engineering either directly after their preparation (with or without cell
entrapment) or after formulation as scaffolds. Hydrogel-based scaffolds are a very important class of
scaffolds due to the ability to tailor their mechanical characteristics to mimic those of natural tissues.
Hydrogel scaffolds are used in particular to provide bulk andmechanical structures to a tissue construct,
whether cells are suspended within or adhered to the 3D hydrogel framework. When the cellular-
hydrogel adhesion is preferred over the suspension within the scaffold, inclusion of appropriate peptide
moieties on the surface or throughout the bulk of the hydrogel scaffold can significantly increase the
extent of cellular attachment. For instance, one of the most successful approaches to facilitate cellular
attachment is the incorporation of the RGD (arginine–glycine–aspartic acid) adhesion peptide
sequence. Inclusion of these RGD domains in hydrogels has shown improved cellular migration,
proliferation, growth, and organization in tissue regeneration applications.30,31 In addition, a variety of
cells have been shown to favorably bind to the RGD-modified hydrogel scaffolds. These cells include
endothelial cells (ECs), fibroblasts, smooth muscle cells (SMCs), chondrocytes and osteoblasts.
2.4.3. Hydrogels as barrier against restenosis
Hydrogels can be used to enhance the healing response following a tissue injury where they can be
usedas barriers in order to avoid restenosis or thrombosis due topost-operative adhesion formation.32,33
It has been found that forming a thin hydrogel film intravascularly through interfacial
photo-polymerization can inhibit restenosis by reducing the intimal thickening and thrombosis.32,33
The reduction in the intimal thickening is due to acting of the hydrogel thin film as a barrier preventing
platelets, plasma proteins and coagulation factors from being in direct contact with the vascular walls
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where the contact of these factors with vessel walls would encourage smooth muscle cell proliferation,
migration, and matrix synthesis and consequently cause restenosis. Hydrogels based on poly(ethylene
glycol-co-lactic acid) diacrylate, for instance, were developed through bulk photo-polymerization on
intraperitoneal surfaces where they were able to prevent fibrin deposition and fibroblast attachment at
the tissue surface.34,35
2.4.4. Hydrogels as drug depots
One of the most common applications of hydrogels is their use as localized drug depots. This is
attributed to their highly hydrophilic nature, biocompatibility and the ability to control and trigger the
drug release in a smart manner from them through the interaction with bio-molecular stimuli.36–38
Hydrophilic macromolecular therapeutic agents, such as some proteins or oligonucleotides are
innately compatible with hydrogel matrices. In addition, the delivery kinetics can be managed
according to the desired drug release schedule via controlling the swelling degree, crosslinking extent
and the biodegradation rate of hydrogels. Photo-polymerizable hydrogels are especially attractive for
localized drug delivery due to their ability to adhere and conform to targeted tissue when formed in situ.
Moreover, the drug delivery ability of hydrogels can be used simultaneously with their functioning as
barrier layer, as described earlier, to deliver drugs locally and at the same time inhibit any
post-operative adhesion formation. In one example, biodegradable photo-polymerized hydrogel layers
have been formed on intraperitoneal tissues to locally release urokinase plasminogen activator, tissue
plasminogen activator and ancrod.34,39 These developed formulations demonstrated a significant
reduction in adhesion formation as compared to using intraperitoneal injections or hydrogel barriers
alone. In another example, mono- and multilayer hydrogels formed on the inner surface of blood
vessels through interfacial photo-polymerization have been utilized for intravascular drug delivery.39,40
2.5. Design criteria for hydrogel scaffolds in tissue engineering
The extracellular matrix (ECM) is the extracellular component of natural tissue that provides structural
support to the cells as well as performing various other important functions. Hence, the ECM is one of
the most significant guides in the design of scaffolds for tissue engineering. The ECM is a hydrophilic
3D micro-matrix with two major solid structures; collagen fibers and the proteoglycan filaments. The
collagen fibers present as bundles and extend through the interstitium, providing the tensile strength
and durability for the surrounding tissue. The proteoglycan filaments are coiled structures and made
from protein and hyaluronic acid. Together with the entrapped interstitial fluid, which is a plasma-like
fluid but of a lower protein concentration, ECM demonstrates a gel-like uniformity.41
Hydrogels in tissue engineering must meet a number of design criteria to mimic the ECM and
consequently to function appropriately and promote new tissue formation. These hydrogel scaffolds for
instance, should provide a 3D architecture for cell growth. This architecture better mimics the natural
tissues and allows for morphology and gene expression that cannot be attained in 2D structures.
The design criteria should also include both classical mechanical and physicochemical parameters
(such as biodegradation, porosity and proper surface chemistry), and biological performance
parameters (such as biocompatibility and cell adhesion), as well as demonstrating enhanced
vascularization. In addition, parameters such as accessibility and commercial feasibility should
be considered upon developing hydrogel scaffolds for tissue engineering purposes.
2.5.1. Biodegradation
A basic requirement of a scaffold for tissue engineering is to maintain cellular proliferation and desired
cellular distribution during the anticipated life of the scaffold. In many cases, the scaffold’s life would
be until degradation is complete. Therefore the rate and extent of biodegradation are critical design
considerations for hydrogels in tissue engineering. The significance of scaffold degradation in tissue
culture has been evaluated by examining the cellular viability in non degradable scaffolds. For
instance, PEG and PEG-dimethacrylate (PEGDMA) have been photo-polymerized to produce hydrogel
scaffolds encapsulating bovine and ovine chondrocytes for cartilage regeneration.42,43 After the
photo-polymerization, cells within the scaffold were able to maintain their viability and were evenly
dispersed, but because of the non biodegradability of these PEG-based scaffolds, the cell counts
decreased significantly over time. In a contrary situation, a biodegradable hydrogel scaffold was
developed via photo-polymerization of poly(propylene fumarate-co-ethylene glycol) and used to
encapsulate endothelial cells for vascular cell growth.44 This study showed that the cells were
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distributed throughout the hydrogel scaffold and were actively proliferating. Additionally, cells were
found to spread and migrate in proteolytically degradable hydrogel scaffolds, but they were grouped in
clusters in non degradable hydrogel scaffolds. It was also demonstrated that in proteolytically
degradable hydrogel scaffolds, cells attained an increase in their proliferation rate and ECM production
over cells in non degradable hydrogel scaffolds.39
In spite of the significance of biodegradation as a key factor for hydrogel scaffolds in tissue
engineering, some tissue engineering applications may not require complete scaffold degradation,
such as with corneal replacement or articular cartilage. For these types of tissues, semi-permanent or
permanent scaffolds may be the best choice to replace the basic function of lost or damaged tissue.
In general, degradable hydrogel scaffolds are developed via incorporating cleavable crosslinks
and/or cleavable moieties into the polymer backbone. In the case of biodegradable hydrogel scaffolds,
an important class of degradable scaffolds, degradation is achieved through biological processes,
mainly enzymatic digestion.45 Biodegradable hydrogel scaffolds can also be made by incorporating
naturally biodegradable ECM components, such hyaluronic acid, laminin, fibronectin and collagen.
Moreover, cell-driven degradation of hydrogel scaffolds has been reported by Hubbell et al.46,47
2.5.2. Biocompatibility
Biocompatibility, “the ability of a material to perform with an appropriate host response in a specific
application”,48 is a key design factor for engineered tissue constructs. In other words, biocompatibility
means that no or very limited harmful immunological, toxic, or foreign body responses should take place
as a result of regenerativemedical intervention. This definition of biocompatibility is particularly relevant
in tissue engineering because the nature of tissue constructs is to continuously interact with the body
during the healing and cellular regeneration process, and also during the scaffold degradation. If this
design parameter is not considered, the resulting hydrogel matrix can be fouled or there may be scarring
to the connected tissues, whether these tissues are directly adjacent or linked through vasculature.
One of the main challenges for in vivo biocompatibility of hydrogel scaffolds is the toxic moieties and
chemicals that may be used in the polymerization of synthetic hydrogels or in the crosslinking of
natural polymer hydrogel precursors, especially if reaction conversion is less than 100%. Ingredients
such as unreacted monomers, stabilizers, initiators, organic solvents and emulsifiers which are used in
hydrogel preparation may also be harmful, if they leak to the seeded cells or tissues. For instance,
Irgacure, a commonly used free radical photo-initiator has been found to decrease cell viability even at
limited concentrations.49 Therefore, hydrogel scaffolds developed for tissue engineering should
typically be purified from remaining unreacted hazardous chemicals before use. This purification can
be performed using various techniques such as dialysis or extensive solvent washing. In some cases,
purification of hydrogel scaffolds is more challenging, or even not viable, such as in the case of
hydrogels that are prepared through in situ gelation. This is because the reactants required to
synthesize the hydrogel are injected into the body while still in a pre-polymer solution. Hence,
upon using such in situ gelation techniques, particular caution should be considered to ensure all
ingredients are non toxic and reasonably safe.
2.5.3. Pore size and porosity extent
Hydrogel scaffolds designed for tissue engineering must be highly porous with an open interconnected
geometry, to allow a large surface area relative to the scaffold’s volume. This high, interconnected
porosity will encourage cell ingrowth, uniform cell distribution and assist the neovascularization of the
matrix.50 Not only is the porosity extent important, but many other parameters such as pore size, pore
volume, pore size distribution, pore throat size, pore shape, pore wall roughness and the pore
interconnectivity are equally significant considerations when designing a hydrogel scaffold for tissue
engineering purposes. For instance, pore interconnectivity is critical to ensuring that all cells are within
200mm from the blood supply in order to provide for mass transfer of nutrients and oxygen.51,52 Pore
size is also a very important parameter because if the developed pores were too small, pore blocking
by the cells would occur, inhibiting cellular penetration, ECM production, and neovascularization of the
inner areas of the scaffold. The effect of scaffold pore size on tissue regeneration, and optimum pore
sizes for different purposes have been reported in many recent studies. For instance, it has been
demonstrated that the optimum pore size for neovascularization is 5mm,53 5–15mm for ingrowth of
fibroblast,54 20mm for hepatocytes ingrowth,51 20–125mm for regeneration of adult mammalian
skin,55 and 200–350mm for osteoconduction.56
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2.5.4. Mechanical characteristics
The mechanical characteristics of hydrogels as scaffolds for tissue engineering can have a significant
effect on either attached or encapsulated cells. It is well established that the ECM has a certain level of
isometric tension between the cells in a given tissue, which varies according to tissue type and can be
changed in disease processes. Also, the response of individual cells to changes in these tensions and
stresses can vary from morphological alterations to changes in gene expression.57 For this reason,
hydrogel scaffolds may need to be designed with tissue specific mechanical characteristics.
For instance, it was reported that hydrogel stiffness can be used to control the differentiation of
mesenchymal stem cells.58 One of the main parameters that control the mechanical compliance of
hydrogel scaffolds is the crosslinking density, which can also be used to affect cells encapsulated
within hydrogel networks. For instance, it has been reported that changes in the crosslinking density
of PEG-based hydrogel caused changes in cell growth and morphology.59,60
2.5.5. Surface characteristics
The surface of hydrogel scaffolds is the initial and primary site of interaction with surrounding cells and
tissues. Therefore, both physicochemical and topographical surface characteristics of scaffolds are
vital parameters in controlling and affecting cellular adhesion and proliferation.61 As most cells used in
the engineered tissues are anchorage-dependent, the hydrogel scaffolds should be designed in such a
way to facilitate their attachment. For this reason, hydrogel scaffolds with relatively large and
accessible surface area are advantageous in order to accommodate the number of cells required to
replace or reinstate tissue or organ functions. Surface characteristics of hydrogel scaffolds can be
selectively improved by various approaches including thin film deposition and immobilizations of
adhesive biomoieties such as RGD peptides, growth factors (like bFGF, EGF), insulin, fibronectin
and collagen (Figure 6). This modification can enhance the biocompatibility of the hydrogel
scaffold and consequently, cells can specifically recognize the scaffold. The adhesive biomoieties
can either be covalently linked, electrostatically absorbed, or self-assembled on the surface of
hydrogel scaffolds.62
2.5.6. Vascularization
Vascularization is essential to provide a conduit for nutrient exchange and the elimination of waste
products through perfusion. Formation of new blood vessels in adult tissue (Neovascularization) is
therefore a key design factor for most tissue engineering initiatives. However, designing the
appropriate scaffolds that allow and encourage new blood vessels to grow is a big challenge.
Figure 6. Some approaches for selective enhancement of surface characteristics of hydrogel scaffolds toward
increasing surface-cells attachment and controlled release of regulatory growth factors.
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Vascularizable scaffolds should have high porosity extent, desirable pore sizes and make allowances
for vascular remodeling to take place as tissues mature. In certain tissue engineering applications,
hydrogels have been efficient as vascularizable scaffolds. For instance, alginate-based hydrogel
scaffolds were found to be very successful in vivo in recreation of vascularized bone.63 In general, there
are two main approaches to encourage the vascularization of a tissue engineered scaffold as illustrated
in (Figure 7). In the first approach, vasculogenic growth factors are incorporated into the hydrogel
scaffold to motivate the vasculature from surrounding host tissues to grow into the scaffold. The second
approach involves seeding the hydrogel scaffold with endothelial cells (ECs). Using the first approach,
for instance, gelatin-,64 alginate-,65,66 PEG-,67 and hyaluronic acid-based68,69 hydrogels loaded with
vasculogenic growth factors have been shown to successfully induce the microvessel growth following
implantation process.
One of the other investigated approaches for encouraging vascularization of tissue engineering
scaffolds is based on recruiting endothelial progenitor cells (EPCs). However, relying on the EPCs and
the native surrounding vasculature to invade the implanted scaffolds is a process dependent upon
presence of sufficient amounts of circulating EPCs and can take long time (up to days) to take place.
Generally, cells cannot survive more than few hundred micrometers from blood vessels, so if other
types of cells were incorporated within the hydrogel scaffold, they may subject to necrosis while
waiting for vascular ingrowth. In addition, although EPCs represent a limitless source of cells for in vitro
prevascularization, their differentiation needs to be controlled. In a relatively recent study, Gerecht
et al.70 found that hyaluronic acid-based hydrogels could maintain ESCs in their undifferentiated
state until vascular differentiation was attained.
Figure 7. Schematic illustration of blood vessels formation encouraged by either (a) incorporating of regulatory
growth factors or (b) via seeding of endothelial cells into the porous hydrogel scaffold.
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2.6. Natural polymers-based hydrogels for tissue engineering
Several hydrogels have been developed from natural polymers for tissue engineering applications.
Some of these natural polymer-based hydrogels are described in Table 1. These natural polymers
include for instance, polynucleotides, polypeptides, and different polysaccharides. They are obtained
from a variety of natural origins; for example chitosan is obtained from shellfish exoskeletons whereas,
collagen is obtained from mammals.
Collagen hydrogel fibers are one of the most popular natural polymer-based hydrogel scaffolds in
tissue engineering applications. As shown in (Figure 8), these collagen hydrogel fibers are formed
particularly through self-aggregation and crosslinking (through pyridinium crosslinks) of collagen
molecules in a hydrated environment. Collagen molecules are composed of tropocollagen triple
helixes, where each triple helix results from the self-arranging of three polypeptides strands.
In general, hydrogels based on polymers from natural origins such as collagen are advantageous in
tissue engineering applications due to their intrinsic characteristics of biological recognition, including
presentation of receptor-binding ligands and the susceptibility to cell-triggered proteolytic remodeling
and degradation. However, the use of natural component-based hydrogels has shown some
drawbacks, which involve the complexities associated with purification, immunogenicity and
pathogen transmission.
2.7. Synthetic polymer-based hydrogels for tissue engineering
Hydrogels made from various synthetic polymers were developed for different tissue engineering
applications. Table 2 shows some of these synthetic polymer-based hydrogels.
As described in section 2.6., hydrogels based on natural polymers have demonstrated many
shortcomings including the difficulty of purification, immunogenicity and pathogen transmission.
Although some of these shortcomings can be overcome, greater control over material characteristics
and tissue responses are achievable when using hydrogels based on synthetic analogs.
2.8. Self-assembled peptides (SAPs)-based hydrogels for tissue engineering
Hydrogel scaffolds based on self-assembled peptides (SAPs) are one of the main classes in tissue
engineering applications. SAPs are polypeptides that undergo self-assembly under specific conditions,
typically a hydrophilic environment, to form fibers or other types of nanostructures.13,130–133 Figure 9
shows, for instance, a schematic illustration of the self-assembling of amphiphilic peptide molecules.
These amphiphilic molecules comprise a polypeptide linked to a long chain alkyl tail and also
functionalized with cell adhesion ligand (RGD). The polypeptide represents the hydrophilic region of
the amphiphilic molecule whereas the long chain alkyl part represents the hydrophobic region. These
peptide-based amphiphilic molecules undergo self-assembly into a fibrous crosslinked hydrogel
scaffold (arranged in ribbon-like parallel arrays). A variety of amphiphilic SAPs-based hydrogels have
been used in various tissue engineering applications.130,134,135 These SAPs-based hydrogels can also
be used to incorporate bioactive molecules and allow their controlled release. SAPs-based hydrogels
can also be chemically conjugated to different moieties to allow signaling to cell surface receptors and
to enhance cellular adhesion. For instance, SAPs-based hydrogels have been attached to fibronectin
and laminin peptide domains.135 A further class of SAPs-based hydrogels has been developed by
Zhang et al.136,137 In this class, the synthesized functionalized-peptides were self-assembled into beta
sheets, which subsequently converted into hydrogels. The results of the studies showed that these
developed SAPs-based hydrogels are very promising in generating 3D environments for cell culture and
tissue engineering applications.
In spite of the many superior advantages of using SAPs, such as their effectiveness in forming tissue-
like hydrogels, the absence of cross-linking agents to remove and the relatively easy functionalization,
unfortunately they demonstrate poor mechanical characteristics. Consequently, they cannot be used
for tissue engineering applications that require scaffolds with high mechanical integrity.
2.9. Fabrication of hydrogel scaffolds for tissue engineering
2.9.1. Emulsification
Emulsification is the most commonly used technique for fabricating hydrogel nano- and microparticles
as illustrated in (Figure 10). Emulsification process involves agitation of a multi-phase mixture to
generate small aqueous droplets of hydrogel precursors within a hydrophobic medium
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(such as oil or organic solvent). The droplets size can be controlled by the viscosity of the hydrogel
precursor, the extent of mechanical agitation and through using of surfactants that can control the
surface tension between the two phases as well as preventing aggregation of the resulting hydrogel
particles. The hydrogel precursor droplets can be crosslinked using different crosslinking mechanisms
to produce spherical nano- or microgels.
Emulsification can be utilized to develop gel particles from a wide range of natural and synthetic
polymers such as chitosan, polylactic acid, polylactic-co-glycolic acid, collagen, agarose and alginate.
Cell-laden gel particles can be fabricated through the addition of cells to the aqueous phase containing
the hydrogel precursor.138 Emulsification can be also used to encapsulate embryonic stem cells (ESCs)
within hydrogel microparticles as an in vitro culture, to develop more controllable environments for
differentiation.139 The main advantage of the emulsification process is the ease with which it can be
used to develop gel particles. However, emulsification also has a number of potential limitations.
For instance, the shape of the fabricated gels is limited to spheres and in spite of the ability to control
the resulting sizes, there will always be a wide particle size distribution.
2.9.2. Lyophilization
Lyophilization (freeze-drying) depends on the rapid cooling of a sample to produce thermodynamic
instability within it, leading to a kind of phase separation. This is followed by [under vacuum]
sublimation of the solvent, leaving behind voids and pores. This approach has been used extensively
for production of porous hydrogel matrices for tissue engineering. For instance, Wu et al.140 have
reported the preparation and assessment of collagen-chitosan hydrogel scaffolds crosslinked with
glutaraldehyde for adipose tissue engineering. Both in vitro and in vivo characterizations demonstrated
that the developed collagen-chitosan hydrogel scaffolds seeded by preadipocytes cells were
biocompatible, induced vascularization and were able to form adipose tissue. In another study,
agarose hydrogel scaffolds with linear porous channels were fabricated using a modified
Table 1. Some natural polymer-based hydrogels for tissue engineering applications.
Hydrogel pre-polymer Used cells Developed tissue Ref.





– Vascular Tabata et al. and
Peattie et al.[64,68]
h-ESCs Vascular [70]
Peptide amphiphile–Ti composite Osteoblasts Bone [76]
HA, Chondroitin Sulfate, Gelatin Fibroblasts ECM [77]
Fibrin Chondrocytes Cartilage [78]
Bone marrow cells Cardiovascular [79]
– Skin [80]
Chondrocytes Cartilage [81]
Alginate Chondrocytes Cartilage [82]
Chondrocytes Facial [83]
– Vascular [65,66]
Alginate, HA – Cartilage/Bone [63]
Collagen Chondrocytes Cartilage [84]
– Skin [85]
– Neural [86]
Astroglial cells Spinal cord [87]
Collagen, Alginate – Vocal Cord [88]
Collagen, HA Chondrocytes Cartilage [89]
PLLA, Agar, Gelatin Chondrocytes Cartilage [90]
HA, Collagen Chondrocytes Cartilage [91]
HA, Alginate, Carboxymethylcellulose Hepatocytes Cardiovascular [92]
HA–Gelatin – Vocal Cord [93]
Gelatin – Vascular [64]
Dextran h-ESCs Vascular [94]
Chondroitin sulfate, HA – Skin [95]
Chitin/hydroxyapatite COS-7 cells Bone [96]
HA derivatives NIH3T3 cells - [97]
Agarose carbomer Glial cells Neural [98]
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lyophilization method.141 In this method, one end of a pillar of agarose was subjected to a block of dry
ice immersed within a pool of liquid nitrogen. Hence, the resulting uni-axial temperature gradient led to
the formation of ice crystals, oriented in the direction of the gradient. Then, upon sublimation of water
during the second step of the lyophilization process, a highly linear network of porous channels was
produced with dimensions suitable for cell infiltration. These agarose-based hydrogel scaffolds
fabricated with this procedure showed promising axonal regeneration in a spinal cord injury model.142
Recently, an alternate lyophilization method was also reported by Ricciardi et al.143 for developing
hydrogel scaffolds. This method involves repeated freeze–thaw cycles to avoid the incomplete phase
separation occurring during the initial freezing step which may lead to formation of a polymer-lean
phase inside the scaffold. Repeating the freezing step allows further phase separation of the
polymer-lean phase within the matrix pores, forming a new more diluted polymer-lean phase and
a more concentrated polymer-rich phase, and consequently allowing larger pores formation.
Figure 8. Schematic illustration showing the basic structure of collagen hydrogel fibers. Images were adapted
with modification from Buehler.99
Table 2. Some synthetic polymers-based hydrogels for tissue engineering applications.
Hydrogel pre-polymer Used cells Developed tissue Ref.
PEG–PLA Osteoblasts Bone [100,101]
PEG Fibroblasts Bone [102]






Mesenchymal (MSCs) Cartilage [111]
Chondrocytes, MSCs Cartilage [112,113]
– Intraperitoneal [114]
Islet of Langerhans Pancreatic [115]
– Vascular [32,33]
– Vascular [67]
MSCs, Primary smooth muscle Vascular [116]
Smooth muscle cells Vascular [117]
Endothelial cells Vascular [118]
PEGDA – Vascular [119]
Osteoarthritic chondrocytes Cartilage [120]
PEG–PLA Chondrocytes Cartilage [121,122]
Islet of Langerhans Pancreatic [123]
PEG–PLA–PVA Chondrocytes Cartilage [124]
PEO Semi-IPN Chondrocytes Cartilage [42,43]
PVA Chondrocytes Cartilage [49]
PEG, PEG/PLA – Intraperitoneal [34,35]
PHEMA–MMA – Neural [125]
PHEMA – Eye [126]
Myoblasts Skeletal Muscle [127]
– Spinal cord [128]
Dex-MA-LA & Gel-MA ECs & SMCs Vascular [129]
PEG: poly(ethylene glycol), PEGDA: poly(ethylene glycol) diacrylate, PLA: poly(lactic acid), PEO: poly(ethylene oxide), PVA: poly(vinyl alcohol),
PHEMA: poly(hydroxyl-ethyl methacrylate), IPN: interpenetrating polymeric network, SMC: smooth muscle cell, Dex-MA-LA: methacrylated
dextran-graft-lysine, Gel-MA: methacrylamide-modified gelatin
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In spite of the suitability of lyophilization for fabrication of porous scaffolds, this technique
demonstrates a difficulty in precisely tuning pores size, needs relatively long processing time,
and results in relatively poor mechanical characteristics. In addition, lyophilization often leads to
the formation of a surface skin, due to matrix collapse at the scaffold–air interface as a result of
the interfacial tension change that occurs during solvent evaporation.144
2.9.3. Emulsification-lyophilization
In this fabrication technique, polymeric emulsions composed of dispersed aqueous phase and organic
dispersion medium or vice versa, with a suitable biodegradable polymer dissolved in the dispersed
phase, are lyophilized to produce porous biodegradable scaffolds with different pore sizes and
inter-connectivities. This method was utilized to develop scaffolds with porosity extent of about
95% and pore size of up to 200mm.145
2.9.4. Solvent casting-leaching
Solvent casting–leaching can be considered as the simplest technique for developing porous scaffolds
with almost uniform pore size.146 The procedure includes the casting of an organic polymer solution
Figure 9. Schematic illustration of the self-assembled peptide-amphiphiles (SAPs) functionalized with cell
adhesion ligand (RGD) into fibrous crosslinked hydrogel scaffold for bone tissue engineering applications.
Images were adapted with modification from Hartgerink et al.134
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containing a crosslinker and salt particulates, followed by solvent evaporation and dissolution of
the entrapped salt particulates in water. This approach however, has some shortcomings, in that the
resulting scaffold might contain residual salt particulates. This technique can also only be used to
develop thin film scaffolds. Production of thin scaffold membranes with an open-cell morphology
and relatively high porosity (up to 93%) has been reported using this technique.147 For developing
a 3D scaffold, porous scaffold membranes were laminated as multi-layers with different
anatomical structures.147
2.9.5. Gas foaming-leaching
In this method, an effervescent salt is used as a gas foaming agent to develop the porous structure of the
scaffolds. As illustrated in (Figure 11), a polymeric gel containing homogeneously dispersed salt particles
such as ammonium bicarbonate is cast in a suitable mold, followed by immersion in hot water. The
evolution of carbon dioxide and ammonia gases, followed by the leaching out of residual ammonium
bicarbonate particles from the solidifying hydrogel lead to the formation of a porous matrix with high
interconnectivity. The scaffolds resulting from this approach showed a macro-porous open cellular
structure with uniform pore sizes in the range of 100 to 200mm.148 The method was further modified by
adding acidic salt, citric acid, into the hot water before immersing the gel mold.149 This citric acid salt
reactswith the ammoniumbicarbonate, facilitating evolution of the gases and resulting in the production
of macro-porous scaffolds with more than 90% porosity and pore sizes of 200mm. In this modified
method, both porosity and mechanical characteristics could be controlled via adjusting the rate of
evolution of the foaming gases through controlling the reaction rate between the two salts. Using the
same fabrication approach, injectable highly open porous microspheres scaffolds with average particle
size of 250mmwere also developed.150 These injectable scaffolds had average pore size of 30mm,which
allowed promising cell infiltration and seeding, as demonstrated by cultivation with fibroblasts.
Figure 10. Schematic illustration of emulsification technique for fabrication of hydrogel particles scaffolds for
tissue engineering applications.
Figure 11. Schematic illustration of gas foaming-leaching technique for fabrication of porous hydrogel scaffolds
for tissue engineering applications.
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2.9.6. Photolithography
The photolithography technique was developed particularly for micro- and nano-electronics
applications. More recently, photolithography has been utilized for a variety of biomedical applications
to develop micro-engineered hydrogel scaffolds. This has been partly enabled by the preparation of
different natural and synthetic photo-crosslinkable polymers that can undergo crosslinking to form
hydrogels.151 Photolithography depends on the exposure of a thin film of photo-crosslinkable polymer
to UV light through a mask as shown in (Figure 12). Then, as the light reaches the photo-sensitive
polymer through the transparent areas of the mask it causes photoreactions that crosslink the polymer.
Recently, other similar techniques have also been utilized to develop hydrogel matrices through
focusing and scanning light. For instance, the development of photo-crosslinkable matrices that utilize
blue light for crosslinking has further advanced and enhanced the safety of this technology for tissue
engineering purposes.49 Also, in a similar photolithography technique known as laser scanning
lithography, a laser light has been applied to crosslink photo-sensitive hydrophilic polymers in specific
sites.152 With the aid of similar strategies, it was possible to construct 3D complex tissue scaffolds one
layer at a time.153 Moreover, the use of focused light to conjugate bioactive moieties to and/ or within
pre-fabricated hydrogel scaffolds was also reported.154 For instance, this method has been used to
pattern photo-active RGD peptides within agarose-based hydrogel, to develop adhesive pathways that
enabled directed cell migration into the hydrogel.
In spite of the significance of photolithography as a fabrication technique for hydrogel scaffolds,
it has some potential disadvantages that include the necessity for photo-crosslinkable polymers and
the harmful effects of UV light on cell function, in addition to the cytotoxicity associated with the use of
photoinitators. Moreover, because photolithography is essentially a 2D method, it develops matrices
that may require further assembly to generate 3D scaffolds.
2.9.7. Electrospinning
Electrospinning is one of the most significant techniques used for the fabrication of interconnected
porous scaffolds for tissue engineering purposes. As schematically illustrated in (Figure 13), the
electrospinning technique depends in particular on the use of an external electric field to draw
microfibers from a charged polymer solution at the end of a capillary tube. Charging of the polymer is
achieved through the application of a high voltage, and is then drawn as a thin jet filament toward an
oppositely charged plate or rotating collector according to the desired orientation of the collected
fibers.155 The characteristics of the resulting fibers such as diameter, morphology and porosity can be
controlled through adjusting the processing parameters including the applied voltage, temperature,
polymer solution viscosity and conductivity.156
Electrospinning has been utilized to develop various types of hydrogel scaffolds such as the ultrafine
(submicron) porous fibrous hydrogels based on a combination of polyacrylic acid and polyvinyl alcohol
(PVA).157 In these fabricated fibrous hydrogel scaffolds, the majority of the interfiber pores were
inter-connected, which is advantageous for tissue engineering to allow cell–cell interaction and
migration.157 In another study, a combination of electrospinning and salt-leaching methods was used
Figure 12. Schematic illustration of photolithography technique for fabrication of hydrogel scaffolds for tissue
engineering applications.
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to fabricate collagen-hyaluronic acid hydrogel nanofibers.158 In this study, NaCl salt particles were used
to induce interfiber porosity. In vitro studies revealed that the fabricated collagen-hyaluronic acid
hydrogel fibers could support adhesion, proliferation and retention of the in vivo morphology of bovine
chondrocyte cells.158 In other reported investigations, various nano- and micro-nonwoven hydrogels
based on natural polymers such as fibroin, fibrinogen, silk, and collagen have been fabricated for
tissue engineering purposes with the aid of electrospinning.159 It was also reported that different types
of cells can attach, proliferate and differentiate within these kinds of fibrous hydrogel scaffolds,
demonstrating their potential in tissue engineering applications.155 However, using electrospinning to
develop hydrogel scaffolds for tissue engineering is still limited due to many drawbacks, such as
limited control over the porosity and pore size, relatively bad mechanical properties and, in particular,
the inability of this technique to fabricate 3D hydrogel scaffolds.160
2.9.8. Microfluidic
The microfluidic technique was used to create a variety of hydrogel microstructures, through the
creation of single or multi-phase flows within microfluidic channels. In most cases, cells, and the
selected polymeric hydrogel precursors, are allowed to flow through microchannels that control the
resulting shape of the developed hydrogel as shown in (Figure 14).161 By layering these cell-loaded
microgels on each other, complex 3D structures can be developed in which multiple types of cells can
be patterned relative to each other to recreate tissue-like complexity. Also, two-phase systems
composed of hydrophilic droplets in a hydrophobic medium were used to develop hydrogel droplets
with controllable physicochemical characteristics.
A combination of microfluidics and photolithography has been used recently to engineer unique
hydrogel scaffolds.162,163 In this study, microfluidic channels were used to produce micro-engineered
Figure 13. Schematic illustration of the basic electrospinning setup.
Figure 14. Schematic illustration of microfluidic technique.
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hydrogel scaffolds, through the exposure of a stream of polymeric gel precursors to light that passed
through a pre-designed mask and was focused with a microscope.162 As the fluid was exposed to the
light, the polymeric precursors were crosslinked to produce microgels that were then collected at the
outlets of the microchannels. With this combined fabrication approach, it was possible to encapsulate
cells in hydrogel scaffolds of carefully controlled shapes.162,163
2.9.9. Micromolding
Micromolding is another fabrication technique that is capable of generating hydrogels with controlled
size and porosity. This technique has become particularly attractive with the development of soft
lithography, which has enabled the easy fabrication of molds based on poly(dimethyl siloxane) from
prefabricated silicon wafers, and also the development of fluoro-based micro-mold nanoscale particles
of controlled structures.164 In this technique, to develop a micro-molded hydrogel, polymeric hydrogel
precursors are initially molded and subsequently gelled to produce structures of variety of shapes,
morphologies and sizes.165– 167 Micromolding has been used to fabricate micro-engineered hydrogels
from different polymers such as chitosan,165 PEG168 and hyaluronic acid.166 However, this technique
was unable to fabricate micro-engineered hydrogels of controlled features from polymers such as fibrin
and alginates that require the addition of gelling agents such as divalent and polyvalent ions. To avoid
this shortcoming, a new method has been applied which includes micro-molding of alginate hydrogels
using other gels as templates.169 In this method, the polymeric gel precursor is initially formed using
the hydrogel mold, followed by adding a crosslinking agent across the mold to crosslink the resulting
matrices into a new gel. Using this procedure, alginate microstructures were fabricated and have
revealed a promising ability to encapsulate cells within controlled structures. Micromolding has also
been a successful technique in developing 3D interconnected macro-porous hydrogel matrices, where
the hydrogel structures were formed around a packed bed of polymeric beads that were subsequently
dissolved.170 Hydrogels with microfluidic channels within their structures were developed with the aid
of a dissolvable gelatin-based template.171
2.9.10. Three-dimensional organ/tissue printing
Three-dimensional (3D) organ/tissue printing is a novel approach in tissue engineering and it is based
on layered strand- or dropwise deposition of cell-laden hydrogels.172,173 This rapid prototyping-derived
technique is beneficial in developing 3D scaffolds with a predesigned external shape and internal
morphology, and also with definite cell placement.
In this technique (Figure 15), a computer-aided design of the implant is translated by the rapid
prototyping machine into a layered, cell-laden hydrogel construct with predefined external shape and
internal morphology, for the use either in an in vitro model or in vivo grafting. This can be achieved via
using multiple printing heads, each containing a specific cell type and/or hydrogel, which enables
printing of heterogeneous constructs.
In 3D organ/tissue printing, the use of hydrogel scaffolds is important as they provide a support
matrix for the embedded cells with a highly hydrated microenvironment that is adjustable to nutrient
and oxygen diffusion. In general, the main hydrogel requirements for 3D organ printing involve: (a) non
cytotoxicity, (b) preservation of the printed shape and internal morphology after the deposition,
(c) conferring adequate stability and mechanical characteristics for in vitro culture and in vivo
implantation, (d) preserving cell viability and function, and (e) easy handling of the printed scaffolds.
Besides, the hydrogel should ideally provide the embedded cells with the suitable biochemical and
physical stimuli to guide various cellular processes such as migration, proliferation, and differentiation.
Furthermore, for optimal use in organ printing, fast gelation is essential during stacking of subsequent
cell-laden hydrogel layers.
Some of the common hydrogels used for 3D organ/tissue printing include alginates,176,177 collagen,
and Pluronics.178 Most of these hydrogels however, showed some shortcomings such as a lack of
adhesive/biomimetic sequences, limited mechanical characteristics, and instability in culture.
Hydrogels have been used through 3D organ/ tissue printing technique to develop tubular-like
structures laden with endothelial cells176 and to design various co-culture systems.179–181
2.10. Hydrogel scaffolds for cardiac tissue engineering
Cardiac tissue engineering is an integrated process involving both cells (such as cardiomyocytes and
stem cells) and supporting matrices. Because of their softness, viscoelastic nature, and tissue-like
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characteristics, hydrogels have been used as supporting matrices in cardiac tissue engineering and to
deliver cells into infarcted cardiac muscle. These hydrogels not only maintain cells in the infarcted area,
but also offer support for restoring myocardial wall stress, and cell survival and functioning.
Hydrogels based on both natural and synthetic polymers are suitable for cardiac tissue engineering.
Chitosan, collagen, laminin, gelatin, matrigel, sodium aliginate, and hyaluronic acid (hyaluronan) are
the most commonly used natural polymers in developing hydrogels for cardiac tissue engineering
applications. These natural polymers have structures very similar to the molecules in biological
organisms, thus reducing the possibility of immune response when implanted in vivo. Synthetic
polymers used for developing hydrogel matrices for cardiac tissue engineering include polylactide
(PLA), polylactide-co-glycolic acid copolymer (PLGA), poly(ethylene glycol) (PEG), polycaprolactone
(PCL), polyurethane (PU), and polyacrylamide (PAAm). The use of synthetic polymers is advantageous
over natural polymers due to ease of tailoring their physicochemical characteristics, such as water
affinity, modulus, and degradation rate, to meet the requirements of cardiac muscle tissue engineering.
However, potential cytotoxicity is a major concern upon using synthetic polymers. To date, only PLA,
PEG, and PLGA have been approved by the FDA for clinical applications but some other polymers such
as PU and PAAm have already been found to be non-toxic in vitro and in vivo.
Over the last decade, many hydrogel matrices have been developed for cardiac tissue engineering
purposes. For instance, Singelyn et al.182 have generated injectable porcine myocardium hydrogel,
which supported the survival of cardiomyocytes and the migration of ECs and SMCs in vivo. Further
in vivo study revealed the infiltration of both the ECs and SMCs into the hydrogel, and showed that
vascularization was improved within the hydrogel matrices. However, this in vivo study was performed
on a normal rat heart, thus the findings need to be verified using a myocardial infarction (MI) heart
model. In another study,183 hollow fibrin hydrogel tubes populated with neonatal cardiomyocytes were
implanted into the femoral artery of adult rats. These fibrin hydrogel/cardiomyocytes constructs formed
Figure 15. (a) Organ/tissue printing using fiber deposition. Illustration was adapted with modification from 174,
(b) macroscopic view of the dual graft (heterogeneous tissue formation in a printed construct implanted
subcutaneously in mice) at 6 weeks; dashed line represents the transition zone between (left) printed MSCs
in Matrigel and (right) EPCs in Matrigel/hematoxylin and eosin staining, scale bar ¼ 200mm. Image was
adapted from 175.
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a mature cardiac tissue with a relatively dense capillary network after 3 weeks of implantation.
The resulting cardiac tissue demonstrated all normal cardiac functions, including the contractility under
electric stimulation and synchronous pacing with an external electric signal. Huang et al. in their recent
studies184–186 have embedded rat cardiomyocytes within fibrin hydrogel and found that their
contractility can be maintained up to two months with normal pacing ability.
Matrigel, an ECM-mimicking hydrogel produced by mouse Engelbreth-Holm-Swarm tumors, has been
used as a delivery carrier to deliver genetically modified human MSCs into an infarcted heart. The study
demonstrated that MSCs survival was significantly improved under the ischemic and apoptotic
environment.187 Matrigel has also been combined with other natural polymers to improve cell
proliferation and angiogenesis in vivo. For instance, Giraud et al. showed that Matrigel/collagen
hydrogel significantly enhanced heart function after implantation into acute MI rat hearts.188 Besides,
the implantation of Matrigel/collagen hydrogel and H9C2 cardiomyoblasts in an acute rat MI model
was found to significantly increase the cell engraftment rate.189 In a relatively recent study, Matrigel was
also incorporated into fibrin hydrogel to encapsulate cardiomyocytes. The encapsulated
cardiomyocytes were able to retain their normal function for 10 days.190
Synthetic polymer-based hydrogels have also been investigated for cardiac tissue engineering.
For instance, Wang et al.191 developed a hydrogel based on PEG derivative (PEG–PCL–PEG triblock
copolymer) in a combination with a-cyclodextrin to encapsulate bone marrow MSCs and delivered it to
a rabbit MI site. Walker et al. have developed and implanted poly(ethylene terephthalate) (PET) mesh
reinforced PHEMA hydrogel into the canine epicardium.192,193 This study demonstrated absence of any
significant fibrosis or thickening for 12 months after the implantation. However, a trace calcification was
observed on the gel after 9 and 12 months of implantation, raising the concern of biocompatibility of
the developed PET/PHEMA constructs over a long timeframe.
2.11. Challenges associated with the use of hydrogel scaffolds for tissue engineering
In spite of the relatively successful clinical translation of several engineered tissues, such as lung
tracheal segments194 and tissue engineered bladders,195 various significant challenges are still
associated with the use of hydrogel scaffolds and also with the applied scaffolding techniques in
mimicking natural ECMs.196 Some of these challenges include, for instance; (1) poor cell penetration
and irregular cell seeding due to the lack of appropriate spatial and temporal control (despite great
advances in scaffold fabrication methods), (2) difficulties associated with engineering complex tissues
with multiple cell types and unique ECM composition in spite of the promising success in engineering
tissues composed of a single type of cells, (3) the poor mechanical properties of hydrogels at both
macroscopic and microscopic levels, which tends to limit their applications to soft and non
load-bearing tissues, and (4) the lack of complex microvasculature in most of the engineered tissues,
which leads to a considerable loss of both viability and function of the seeded cells due to a resulting
deficiency in transportation of nutrients and signaling molecules.
2.12. Conclusions
In summary, the scientific research on development, characterization and evaluation of various classes
of hydrogels as potential scaffolds for tissue engineering applications has much progressed over the
last decade. This recent focus on using hydrogels is mainly attributed to their superior biocompatibility
and inherent similarity to ECM. Besides, hydrogels are highly customizable as 2D and 3D networks, with
a wide range selection of available natural or synthetic constituents and fabrication techniques.
In this review, an attempt was made, from the materials science point of view, to provide an overview
of the different classes of hydrogels, the available approaches for fabricating hydrogel scaffolds with
specific features, and the recent discoveries and applications of hydrogels in tissue engineering.
Special attention was also given to the various design criteria toward an efficient hydrogel scaffold.
The challenges associated with the use of hydrogel scaffolds were also described.
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